We are live on ! Find out more
BWP

Barlow Wealth Partners Portfolio holdings

AUM $926M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+20.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$790M
AUM Growth
+$25.3M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
39.45%
Holding
155
New
8
Increased
46
Reduced
41
Closed
19

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$16.5M
2
ASML icon
ASML
ASML
+$13M
3
HLI icon
Houlihan Lokey
HLI
+$3.75M
4
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$2.97M
5
V icon
Visa
V
+$1.64M

Sector Composition

Rank Sector Weight
1 Technology 29.01%
2 Financials 21.79%
3 Communication Services 10.73%
4 Industrials 9.07%
5 Healthcare 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROK icon
151
Rockwell Automation
ROK
$52.4B
-875
Closed -$234K
SO icon
152
Southern Company
SO
$109B
-3,120
Closed -$277K
TROW icon
153
T. Rowe Price
TROW
$26.1B
-58,212
Closed -$6.21M
UPS icon
154
United Parcel Service
UPS
$89.7B
-1,638
Closed -$215K
CNR
155
Core Natural Resources Inc
CNR
$4.02B
-142,640
Closed -$15.4M

Similar funds

Barlow Wealth Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Barlow Wealth Partners held 155 positions worth $790M, up 3.3% from $765M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barlow Wealth Partners's Q4 2024 filing shows 8 new, 46 increased, 41 reduced and 19 closed positions. Its largest new stake was Nice: 92,449 shares worth $15.5M. The largest sale was AstraZeneca, an estimated $18.5M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Barlow Wealth Partners's largest Q4 2024 buy was Nice: 92,449 shares worth $15.5M.
  • Barlow Wealth Partners added most to Houlihan Lokey in Q4 2024, an estimated $3.75M increase.
  • Barlow Wealth Partners's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $10.5M.
  • Barlow Wealth Partners fully exited AstraZeneca in Q4 2024, selling an estimated $18.5M.
  • Barlow Wealth Partners's ten largest holdings make up 39% of its $790M portfolio in Q4 2024.
  • Barlow Wealth Partners opened 8 new positions and closed 19 in Q4 2024.
  • Barlow Wealth Partners's portfolio value rose 3.3% quarter-over-quarter to $790M.

Based on Barlow Wealth Partners's 13F filing for Q4 2024, filed 17 Jan 2025.